AQP4 and central nervous system cancer: Future research should focus on (1) clarifying causal links between AQP4 dysregulation and glymphatic failure in gliomas, (2) identifying biomarkers of AQP4 activity and localization for patient stratification, and (3) developing BBB-penetrant, isoform-selective interventions.